Search Results - "ZEIN, Nizar N"

Refine Results
  1. 1

    Three‐dimensional print of a liver for preoperative planning in living donor liver transplantation by Zein, Nizar N., Hanouneh, Ibrahim A., Bishop, Paul D., Samaan, Maggie, Eghtesad, Bijan, Quintini, Cristiano, Miller, Charles, Yerian, Lisa, Klatte, Ryan

    Published in Liver transplantation (01-12-2013)
    “…The growing demand for liver transplantation and the concomitant scarcity of cadaveric livers have increased the need for living donor liver transplantation…”
    Get full text
    Journal Article
  2. 2

    Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis by Wieckowska, Anna, Papouchado, Bettina G, Li, ZhengZheng, Lopez, Rocio, Zein, Nizar N, Feldstein, Ariel E

    Published in The American journal of gastroenterology (01-06-2008)
    “…Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D) are growing public health problems, and are strongly associated. The link between the two…”
    Get full text
    Journal Article
  3. 3

    Cytokines in the Pathogenesis of Fatty Liver and Disease Progression to Steatohepatitis: Implications for Treatment by CARTER-KENT, Christine, ZEIN, Nizar N, FELDSTEIN, Ariel E

    Published in The American journal of gastroenterology (01-04-2008)
    “…Nonalcoholic fatty liver disease (NAFLD) has emerged as a growing public health problem worldwide. NAFLD represents a wide spectrum of conditions ranging from…”
    Get full text
    Journal Article
  4. 4

    In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease by Wieckowska, Anna, Zein, Nizar N., Yerian, Lisa M., Lopez, A. Rocio, McCullough, Arthur J., Feldstein, Ariel E.

    Published in Hepatology (Baltimore, Md.) (01-07-2006)
    “…In patients with nonalcoholic fatty liver disease (NAFLD), a liver biopsy remains the only reliable way to differentiate simple steatosis from nonalcoholic…”
    Get full text
    Journal Article
  5. 5

    An apoptosis panel for nonalcoholic steatohepatitis diagnosis by Tamimi, Tarek I. Abu-Rajab, Elgouhari, Hesham M, Alkhouri, Naim, Yerian, Lisa M, Berk, Michael P, Lopez, Rocio, Schauer, Phillip R, Zein, Nizar N, Feldstein, Ariel E

    Published in Journal of hepatology (01-06-2011)
    “…Background & Aims The extrinsic death receptor-mediated pathway of apoptosis is involved in nonalcoholic steatohepatitis (NASH) development. Our aims were to…”
    Get full text
    Journal Article
  6. 6

    Inflamed Liver and Atherosclerosis: A Link Between Histologic Severity of Nonalcoholic Fatty Liver Disease and Increased Cardiovascular Risk by Alkhouri, Naim, Tamimi, Tarek Abu-Rajab, Yerian, Lisa, Lopez, Rocio, Zein, Nizar N, Feldstein, Ariel E

    Published in Digestive diseases and sciences (01-09-2010)
    “…Background Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world. It encompasses a spectrum of disease ranging…”
    Get full text
    Journal Article
  7. 7
  8. 8

    The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation by Hanouneh, Ibrahim A., Feldstein, Ariel E., McCullough, Arthur J., Miller, Charles, Aucejo, Federico, Yerian, Lisa, Lopez, Rocio, Zein, Nizar N.

    Published in Liver transplantation (01-09-2008)
    “…Although hyperinsulinemia and its associated metabolic syndrome (MS) have been implicated in the progression of hepatic fibrosis in hepatitis C virus (HCV)…”
    Get full text
    Journal Article
  9. 9

    Sofosbuvir and simeprevir without ribavirin effectively treat hepatitis C virus genotype 1 infection after liver transplantation in a two-center experience by Jackson, Whitney E., Hanouneh, Mohamad, Apfel, Tehilla, Alkhouri, Naim, John, Binu V., Zervos, Xaralambos, Zein, Nizar N., Hanouneh, Ibrahim A.

    Published in Clinical transplantation (01-06-2016)
    “…Background The interferon‐free antiviral regimen, sofosbuvir (SOF) and simeprevir (SIM) without ribavirin has been reported to achieve high sustained virologic…”
    Get full text
    Journal Article
  10. 10

    Recurrent hepatitis C after liver transplantation: On‐treatment prediction of response to peginterferon/ribavirin therapy by Hanouneh, Ibrahim A., Miller, Charles, Aucejo, Federico, Lopez, Rocio, Quinn, Mary Kay, Zein, Nizar N.

    Published in Liver transplantation (01-01-2008)
    “…Sustained virologic response (SVR) in the treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation (LT) remains suboptimal. We…”
    Get full text
    Journal Article
  11. 11

    Ascitic Fluid Lactoferrin for Diagnosis of Spontaneous Bacterial Peritonitis by Parsi, Mansour A, Saadeh, Sherif N, Zein, Nizar N, Davis, Gary L, Lopez, Rocio, Boone, James, Lepe, Maria R, Guo, Linsheng, Ashfaq, Mohammad, Klintmalm, Goran, McCullough, Arthur J

    Published in Gastroenterology (New York, N.Y. 1943) (01-09-2008)
    “…Background & Aims: The diagnosis of spontaneous bacterial peritonitis (SBP) is based on a manual count of ascitic fluid polymorphonuclear cells (PMNs). This…”
    Get full text
    Journal Article
  12. 12

    Clinical Significance of Metabolic Syndrome in the Setting of Chronic Hepatitis C Virus Infection by Hanouneh, Ibrahim A, Feldstein, Ariel E, Lopez, Rocio, Yerian, Lisa, Pillai, Anjana, Zein, Claudia O, Zein, Nizar N

    Published in Clinical gastroenterology and hepatology (01-05-2008)
    “…Background & Aims: The metabolic syndrome (MS) is a unique condition in which the underlying mechanism is related to insulin resistance. In hepatitis C virus…”
    Get full text
    Journal Article
  13. 13

    Metabolomics studies identify novel diagnostic and prognostic indicators in patients with alcoholic hepatitis by Ascha, Mona, Wang, Zeneng, Ascha, Mustafa S, Dweik, Raed, Zein, Nizar N, Grove, David, Brown, J Mark, Marshall, Stephanie, Lopez, Rocio, Hanouneh, Ibrahim A

    Published in World journal of hepatology (08-04-2016)
    “…AIM: To identify plasma analytes using metabolomics that correlate with the diagnosis and severity of liver disease in patients with alcoholic…”
    Get full text
    Journal Article
  14. 14

    Role of ceramides in nonalcoholic fatty liver disease by Pagadala, Mangesh, Kasumov, Takhar, McCullough, Arthur J, Zein, Nizar N, Kirwan, John P

    Published in Trends in endocrinology and metabolism (01-08-2012)
    “…Nonalcoholic fatty liver disease (NAFLD) is a chronic disease with a histological spectrum ranging from steatosis alone, to nonalcoholic steatohepatitis…”
    Get full text
    Journal Article
  15. 15

    Monitoring peripheral blood CD4+ Adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression by Alkhouri, Naim, Hanouneh, Ibrahim A., Lopez, Rocio, Zein, Nizar N.

    Published in Liver transplantation (01-02-2010)
    “…The recurrence of hepatitis C virus (HCV) after orthotopic liver transplantation (OLT) is often associated with rapid fibrosis progression attributed to the…”
    Get full text
    Journal Article
  16. 16

    Ohio solid organ transplantation consortium criteria for liver transplantation in patients with alcoholic liver disease by Hajifathalian, Kaveh, Humberson, Annette, Hanouneh, Mohamad A, Barnes, David S, Arora, Zubin, Zein, Nizar N, Eghtesad, Bijan, Kelly, Dympna, Hanouneh, Ibrahim A

    Published in World journal of hepatology (28-09-2016)
    “…AIM To evaluate risk of recidivism on a case-by-case basis.METHODS From our center’s liver transplant program,we selected patients with alcoholic liver disease…”
    Get full text
    Journal Article
  17. 17

    Cumulative risk of cardiovascular events after orthotopic liver transplantation by Albeldawi, Mazen, Aggarwal, Ashish, Madhwal, Surabhi, Cywinski, Jacek, Lopez, Rocio, Eghtesad, Bijan, Zein, Nizar N.

    Published in Liver transplantation (01-03-2012)
    “…As survival after orthotopic liver transplantation (OLT) improves, cardiovascular (CV) disease has emerged as the leading cause of non–graft‐related deaths…”
    Get full text
    Journal Article
  18. 18

    Cytokeratin‐18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study by Feldstein, Ariel E., Wieckowska, Anna, Lopez, A. Rocio, Liu, Yao‐Chang, Zein, Nizar N., McCullough, Arthur J.

    Published in Hepatology (Baltimore, Md.) (01-10-2009)
    “…Liver biopsy remains the gold standard for diagnosing nonalcoholic steatohepatitis (NASH). We have recently demonstrated that plasma cytokeratin 18 (CK‐18)…”
    Get full text
    Journal Article
  19. 19

    The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis by Ascha, Mustafa S., Hanouneh, Ibrahim A., Lopez, Rocio, Tamimi, Tarek Abu‐Rajab, Feldstein, Ariel F., Zein, Nizar N.

    Published in Hepatology (Baltimore, Md.) (01-06-2010)
    “…Nonalcoholic steatohepatitis (NASH) is a well‐recognized cause of cirrhosis and has been increasingly associated with the development of hepatocellular…”
    Get full text
    Journal Article
  20. 20

    Liver Transplant in Young Adults with Chronic Hepatitis C Virus: An Argument for Hepatitis C Treatment in Childhood by Mohamad, Bashar, Hanouneh, Ibrahim A, Zein, Nizar N, Lopez, Rocio, Matloob, Ammar, Alkhouri, Naim

    Published in Experimental and clinical transplantation (01-04-2016)
    “…We sought to assess the characteristics of hepatitis C virus-positive young adults who received a liver transplant and to evaluate posttransplant outcomes…”
    Get full text
    Journal Article